15051-81-7

Usage

Uses

Used in Pharmaceutical Applications:
10-epi-γ-eudesmol is used as an anti-inflammatory and anti-cancer agent for its potential to treat inflammatory diseases and inhibit the growth of cancer cells. Its ability to modulate immune responses and reduce inflammation makes it a valuable candidate for further research and development in the pharmaceutical industry.
Used in Cosmetic Applications:
In the cosmetic industry, 10-epi-γ-eudesmol is used as an ingredient in skincare products due to its anti-inflammatory and antioxidant properties. Its potential to reduce inflammation and protect the skin from oxidative stress makes it a promising component for various cosmetic formulations.
Overall, 10-epi-γ-eudesmol's diverse applications in both the pharmaceutical and cosmetic industries highlight its potential as a versatile and valuable compound for various therapeutic and skincare purposes. Further research and development are necessary to fully explore and harness its benefits.

InChI:InChI=1/C15H26O/c1-11-6-5-8-15(4)9-7-12(10-13(11)15)14(2,3)16/h12,16H,5-10H2,1-4H3/t12-,15+/m1/s1

Upstream product

• 547-27-3 Epi-Carrisone 
• 55823-40-0 Benzoic acid 1-((2R,4aR,8S,8aR)-8a-hydroxy-4a,8-dimethyl-decahydro-naphthalen-2-yl)-1-methyl-ethyl ester 
• 126654-54-4 eudesmagnolol 
• 126654-55-5 eudeshonokiol A 
• 126654-57-7 2-[(2R,4aR,8R,8aR)-8-(3,5'-Diallyl-2'-methoxy-biphenyl-4-yloxy)-4a,8-dimethyl-decahydro-naphthalen-2-yl]-propan-2-ol 
• 133056-10-7 eudeshonokiol B 
• 2303-31-3 7-epi-cyperone 
• 88494-79-5 1-hydroxy γ-eudesmol 
• 186376-50-1 hinesol 
• 1460-74-8 1α,10α-epoxyhines-11-ol 
• 157192-94-4 <2S-(2RS,6RS,9SR)>-9-<1-(triethylsilyl)oxy-1-methylethyl>-2,6-dimethyl-1,5-cyclodecanedione 
• 157192-96-6 <4S-(4α,4aα,6α,8aα)>-octahydro-4,8a-dimethyl-6-<1-(triethylsilyl)oxy-1-methylethyl>-1(2H)-naphthalenone 
• 157192-99-9 <6R-(6α,8aα)>-2,3,5,6,7,8,8a-hexahydro-4,8a-dimethyl-6-<1-(triethylsilyl)oxy-1-methylethyl>-1(2H)-naphthalenone 
• 67697-24-9 <2S-(2RS,6RS,9SR)>-9-(1-hydroxy-1-methylethyl)-2,6-dimethyl-1,5-cyclodecanedione 

Downstream Products

• 20053-66-1 4-epi-trans-dihydroagarofuran 
• 53840-54-3 (1R,4S,8S,9R)-2,2,4,8-Tetramethyl-3-oxa-tricyclo[6.2.2.0^4,9]dodecane 
• 119765-86-5 11-hydroxy-4,5-seco-endesmane-4,5-dione 

Relevant academic research and scientific papers

An efficient stereocontrolled synthesis of (-)-10-epi-5β,11- dihydroxyeudesmane and (-)-4,10-epi-5β,11-dihydroxyeudesmane

A concise and efficient synthesis of (-)-10-epi-5β,11- dihydroxyeudesmane 1 and (-)-4,10-epi-5β,11-dihydroxyeudesmane 2, via (-)- 10-epi-y-eudesmol 5, was accomplished starting from (+)-dihydrocarvone. The salient feature of our synthesis is the utilization of substrate-directable epoxidation and homogeneous hydrogenation to control the stereochemistry at the C-4 and C-5 positions of the title compounds.

First enantioselective total syntheses and absolute configurations of 4,5-dioxo-seco-γ-eudesmol and 5β,11-dihydroxyiphionan-4-one, two aglycones of naturally occurring sesquiterpenes with new skeletons

A facile synthetic route to two new carbon skeleton sesquiterpenes 4,5-dioxo-seco-γ-eudesmol and 5β,11-dihydroxyiphionan-4-one from (+)-dihydrocarvone has been described. The configuration of the 5β,11-dihydroxyipbionan-4-one was confirmed by stereospecific synthesis.

Total synthesis of neohedycaryol. Its possible role in the biosynthesis of eudesmane sesquiterpenes

The total synthesis of neohedycaryol (4), the C(9)-C(10) double bond regioisomer of the germacrane sesquiterpene hedycaryol, was accomplished in 10 steps from the known dione 6. A Marshall fragmentation of the intermediate mesylate 14 was used to prepare the trans,trans-cyclodeca-1,6-diene ring present in neohedycaryol. During the synthesis of 14, a pronounced example of through-bond interactions (TBI) was observed. The preferred elongated chair conformation of neohedycaryol was demonstrated spectroscopically and by chemical conversion into α-, β-, and γ-eudesmol. These findings indicate that the occurrence of neohedycaryol as a precursor in the biosynthesis of epi-eudesmanes as proposed in the literature is unlikely. The preference of neohedycaryol for the elongated chair conformation further shows that the compound occupies the meso form. This implies that neohedycaryol may act as a precursor in the biosynthesis of both ent- and usual eudesmanes.

Biotransformation of (+/-)-4,8-dimethylcyclodeca-3(E),7(E)-dien-1β-ol and (+)-Hedycaryol by Cichorium intybus

The biotransformation of the synthetic (E,E)-1,5-cyclodecadienol 5 and (+)-hedycaryol (11) by a root suspension of fresh chicory has been investigated.Incubation of 5 with a root suspension gave a 2:1 mixture of epimeric eudesmanediols 7a and 7b whereas 11 was selectively converted into cryptomeridiol (12).An explanation for the obtained results is proposed.

The Synthesis of (+)-Hedycaryol, Starting from Natural (-)-Guaiol

Starting from the readily available (-)-guaiol the germacrane sesquiterpene (+)-hedycaryol can be synthesized in a 7 steps reaction sequence in an overall yield of 16percent.Additionally, (+)-γ-eudesmol has been synthesized, also starting from (-)-guaiol. - Key Words: sesquiterpenes, germacrane, eudesmane, cadinane, γ-eudesmol.

NEUROTROPHIC SESQUITERPENE-NEOLIGNANS FROM MAGNOLIA OBOVATA: STRUCTURE AND NEUROTROPHIC ACTIVITY

Novel sesquiterpene-neolignans, eudesobovatols A (1) and B (2), eudesmagnolol (3), eudeshonokiols A (4) and B (5), clovanemagnolol (6), and caryolanemagnolol (7), have been isolated from the bark of Magnolia obovata.Their structures were elucidated to be sesquiterpenes (eudesmol, 4,4,8-trimethyltricyclo2,5>dodecane-1,9-diol, and clovanediol) combined through ether bond with neolignans such as obovatol, honokiol, and magnolol on the basis of spectral data, degradation, and/or synthesis.Compounds 1, 6, and 7 were found to exhibit interesting neurotrophic activity on a neuronal cell culture system derived from fetal rat hemisphere.

Acid-catalyzed Rearrangement of Hinesol and Related Compounds to Eudesmane Derivatives

Acid-catalyzed rearrangement of hinesol α-epoxide (5a) gave 1α-hydroxyeudesmols (9, 10, 11) together with other spirane-type products (6, 8, 14).The same reaction of α- and β-epoxides of hinesol acetate also provided eudesmane derivatives.These results and mechanistic considerations led us to re-examine the formic acid dehydration reaction of hinesol and it was found that the main product does not have the structure 3 or 4 as assumed by Marshall et al., but is identical with (+)-δ-selinene (21).